VKTX logo

Viking Therapeutics (VKTX) Interest expense

annual interest expense:

N/A
December 31, 2024

Summary

  • VKTX annual interest expense is not available.

Performance

VKTX Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherVKTXincome statement metrics

quarterly interest expense:

N/A
March 31, 2025

Summary

  • VKTX quarterly interest expense is not available.

Performance

VKTX quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherVKTXincome statement metrics

TTM interest expense:

N/A
March 31, 2025

Summary

  • VKTX TTM interest expense is not available.

Performance

VKTX TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

Earnings dates

OtherVKTXincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

VKTX Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

VKTX Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

VKTX Interest expense History

DateAnnualQuarterlyTTM
Jun 2020
-
$20.00K(>+9900.0%)
$20.00K(-95.0%)
Dec 2018
$404.00K(-68.5%)
$0.00(0.0%)
$404.00K(-39.0%)
Sep 2018
-
$0.00(-100.0%)
$662.00K(-27.9%)
Jun 2018
-
$146.00K(-43.4%)
$918.00K(-17.3%)
Mar 2018
-
$258.00K(0.0%)
$1.11M(-13.6%)
Dec 2017
$1.28M(-29.1%)
$258.00K(+0.8%)
$1.28M(-12.1%)
Sep 2017
-
$256.00K(-24.3%)
$1.46M(-10.8%)
Jun 2017
-
$338.00K(-21.9%)
$1.64M(-10.3%)
Mar 2017
-
$433.00K(-0.3%)
$1.83M(+0.9%)
Dec 2016
$1.81M
$434.30K(+0.3%)
$1.81M(+11.1%)
Sep 2016
-
$432.80K(-17.8%)
$1.63M(+12.6%)
Jun 2016
-
$526.80K(+26.6%)
$1.45M(+21.5%)
DateAnnualQuarterlyTTM
Mar 2016
-
$416.10K(+63.9%)
$1.19M(+21.3%)
Dec 2015
$982.20K(+56.2%)
$253.80K(+1.2%)
$982.10K(-7.0%)
Sep 2015
-
$250.80K(-7.2%)
$1.06M(+2.8%)
Jun 2015
-
$270.30K(+30.5%)
$1.03M(+24.2%)
Mar 2015
-
$207.20K(-36.8%)
$826.90K(+31.5%)
Dec 2014
$628.70K(+2466.1%)
$327.90K(+47.9%)
$628.70K(+109.0%)
Sep 2014
-
$221.70K(+216.3%)
$300.80K(+280.3%)
Jun 2014
-
$70.10K(+678.9%)
$79.10K(+445.5%)
Mar 2014
-
$9000.00(+63.6%)
$14.50K(+74.7%)
Dec 2013
$24.50K
-
-
Jun 2013
-
$5500.00(+292.9%)
$8300.00(+196.4%)
Mar 2013
-
$1400.00(0.0%)
$2800.00(+100.0%)
Dec 2012
-
$1400.00
$1400.00

FAQ

  • What is the all time high annual interest expense for Viking Therapeutics?
  • What is the all time high quarterly interest expense for Viking Therapeutics?
  • What is the all time high TTM interest expense for Viking Therapeutics?

What is the all time high annual interest expense for Viking Therapeutics?

Viking Therapeutics all-time high annual interest expense is $1.81M

What is the all time high quarterly interest expense for Viking Therapeutics?

Viking Therapeutics all-time high quarterly interest expense is $526.80K

What is the all time high TTM interest expense for Viking Therapeutics?

Viking Therapeutics all-time high TTM interest expense is $1.83M
On this page